Samsung Biologics Stock Price at 798,000 KRW... Down 1.24% from Previous Day
Samsung Biologics has ranked among the top searched stocks on 6 days within the past month.
As of 9:30 AM on the 20th, Samsung Biologics is trading at 798,000 KRW, down 1.24% from the previous day. This represents a 26.67% increase compared to October 26. Samsung Biologics is known as the holding company for Samsung Group's bio business.
Over the past 5 days, individual investors have net sold 123,132 shares, while foreigners and institutions have net bought 68,691 shares and 50,328 shares, respectively.
On November 18, Samsung Biologics became a market issue with a "surge due to contract manufacturing of COVID-19 treatments."
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Trump Puts Iran Strike on Hold One Day Before Attack... "Full-Scale Offensive If Talks Fail"
- [New York Stock Market] Mixed Close Amid Tech Stock Declines and Stalled Ceasefire Talks
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea

※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.